What is Katalyst Surgical?
Katalyst Surgical operates as a specialized manufacturer and provider of high-precision disposable retina instruments. The company's product portfolio, which includes advanced laser probes, forceps, and scissors tips, is engineered to meet the rigorous demands of modern vitreoretinal surgery. By offering both disposable components and reusable handle systems, Katalyst Surgical addresses the dual needs of surgical efficiency and cost-effectiveness for healthcare facilities. Their market position is further bolstered by a commitment to instrument maintenance and repair services, ensuring that surgical centers maintain optimal performance standards while managing overhead costs effectively.
How much funding has Katalyst Surgical raised?
Katalyst Surgical has raised a total of $1.2M across 2 funding rounds:
Debt
$350K
Debt
$849K
Debt (2020): $350K with participation from PPP
Debt (2021): $849K led by PPP
Key Investors in Katalyst Surgical
PPP
Public-Private Partnership
What's next for Katalyst Surgical?
With the recent infusion of capital, Katalyst Surgical is well-positioned to accelerate its growth strategy, focusing on expanding its footprint in the global surgical retina instrumentation market. The company is expected to prioritize the scaling of its manufacturing capabilities to meet rising demand for high-quality, cost-efficient surgical tools. Furthermore, the strategic allocation of these funds will likely support research and development initiatives aimed at refining their existing product line and exploring new innovations in ophthalmic technology. As the firm matures, the focus will remain on enhancing clinical outcomes for patients while providing surgical facilities with the economic flexibility required in today's healthcare environment.
See full Katalyst Surgical company page
